Intuit’s newly formed venture capital arm will invest in early and growth-stage businesses solving a variety of problems in the financial and business services sectors.

Boston Scientific will pay $269m for the 84% of the thrombectomy technology developer that it does not currently own.

Mass General Brigham Ventures was among the participants in a series A round announced at the launch of the blood stem cell-focused startup.

Vijay Reddy, formerly an AI and deeptech-focused partner at Intel Capital, has departed from its parent company and joined venture firm Clear Ventures in a similar position.

SoftBank Vision Fund 2 helped microbial therapeutics developer Hexagon tip its overall funding to over $108m.

Live Nation, Kering and Foot Locker have backed a capital injection which will support the expansion of livestream shopping platform Ntwrk.

Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Q&A with Jacqueline LeSage, founder and managing director, Munich Re Ventures

Alphabet-backed CRM software provider Freshworks floated above its range and now boasts a market cap of $13.5bn.